Skip to main content
Raffi Tachdjian on Muck Rack

Raffi Tachdjian

  • Owner, docraffi.com
  • Allergist and Immunologist, medschool.ucla.edu
Los Angeles
As seen in: Wiley Online Library, Dove Medical Press, HCP Live, medRxiv, The Journal of Allergy & Clinical Immunology, Annals of Allergy, Asthma & Immunology, Patient Care, Value in Health Journal
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Raffi

Contact Raffi, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

SA17 ON-DEMAND TREATMENTS FOR HEREDITARY ANGIOEDEMA AND HEALTHCARE RESOURCE UTILIZATION IN PEDIATRIC (2-11 YEARS) PATIENTS: A US CLAIMS DATABASE ANALYSIS

|
By Hôpital Jeanne de Flandre, Raffi Tachdjian, Adil Adatia, Emel Aygören-Pürsün, Mauro Cancian, Aharon Kessel, H. Li, Héloïse Reumaux, H. Wedner, Bob Geng, Aditya Sehgal, Paul Audhya, Alice Wang
| Value in Health Journal Verified
1University of California, Los Angeles, School of Medicine, Los Angeles, CA, USA 2University of Alberta, Edmonton, AB, Canada 3University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt, Germany 4Azienda Ospedale Università di Padova, Padova, Italy 5Bnai Zion Medical Center, Haifa, Israel 6Institute for Asthma and Allergy, Wheaton, MD, USA 7Hôpital Jeanne de Flandre, Lille, France 8Washington University School of Medicine, St. Louis, MO, USA 9University of California, San Diego, La...
Open in Who Shared Issue with article?

Small Molecules: What makes them ‘small’ and why is that important? What can we expect?

|
By Raffi Tachdjian
| Annals of Allergy, Asthma & Immunology Verified
Keywords small molecule drugs treatment paradigm targeted therapeutic future Get full text access Log in, subscribe or purchase for full access. References 1. Beck, H. ∙ Harter, M. ∙ Hass, B. ... Small Molecules and their impact in drug discovery: A perspective on the occasion of the 125th anniversary of the Bayer Chemical Research Laboratory Drig Discov Today. 2022; 27(6):1560-1574 Jun 2. Southey, M.W.Y. ∙ Brunavs, M.
Open in Who Shared Issue with article?

Real-World HAE Control with Berotralstat at 18 Months, With Raffi Tachdjian, MD

|
By Raffi Tachdjian
| consultantlive.com
In the second part of his conversation with HCPLive, Raffi Tachdjian, MD, MPH, from the department of pediatrics at the University of California Los Angeles, further contextualized new real-world data demonstrating sustained reductions in hereditary angioedema (HAE) attack rates at 18 months following initiation of berotralstat (ORLADEYO).
Open in Who Shared View Duplicates (2) Issue with article?
See all 33 licensed articles (73 Total)